---
title: "FISHMAN MARK — Ownership Dossier"
canonical: https://whiteintel.dev/entity/bbd3bef7-18ee-5bc4-bcd0-d42dc6c67d40
json: https://whiteintel.dev/api/public/dossier/bbd3bef7-18ee-5bc4-bcd0-d42dc6c67d40
identifier: sec:0001786003
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# FISHMAN MARK

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001786003`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/bbd3bef7-18ee-5bc4-bcd0-d42dc6c67d40  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/bbd3bef7-18ee-5bc4-bcd0-d42dc6c67d40  

## Ownership & control

### Holdings / subsidiaries

- **Beam Therapeutics Inc.** (director) — https://whiteintel.dev/entity/e845a03d-98a7-5a80-ae68-0b21e57416c6

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **FISHMAN MARK**. Human view: https://whiteintel.dev/entity/bbd3bef7-18ee-5bc4-bcd0-d42dc6c67d40 · Structured JSON: https://whiteintel.dev/api/public/dossier/bbd3bef7-18ee-5bc4-bcd0-d42dc6c67d40._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._